PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage biopharmaceutical company advancing novel therapies in immunology and oncology by targeting myeloid ...

Chronic myelomonocytic leukemia (CMML) and chronic myeloid leukemia (CML) are two types of cancers that affect the blood and bone marrow. In both types, certain blood cells multiply out of control.

The researchers credit wider availability of molecular testing and better understanding of the diseases for the emerging targeted therapies in development. As ongoing studies continue to investigate ...

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. Some people live a long time with CMML, but others go on to develop acute myeloid leukemia (AML). Chronic myelomonocytic leukemia ...

Chronic myeloid leukemia (CML) and chronic myelomonocytic leukemia (CMML) are two different types of cancer that affect the blood and bone marrow. In people with CML, the body creates abnormal white ...

A collaboration of scientists from Harvard Medical School has discovered that mice lacking a gene called Bid develop the murine equivalent of human chronic myelomonocytic leukemia. As published in ...

Abbreviations: DS, Dusseldorf Score, GFM, Groupe Francophone des Myelodysplasies CMML Prognostic Scoring System; IPSS, International Prognostic Scoring System; IPSS-R, International Prognostic Scoring ...